{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-163546","form_type":"8-K","ticker":"COGT","cik":"0001622229","company_name":"Cogent Biosciences, Inc.","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.709558+00:00","generated_at":"2026-06-14T04:59:38.403324+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cogent Biosciences prices $150M common stock offering of 12.5M shares at $12.00/share","bullets":["Offers 12,500,000 shares of common stock at $12.00 per share; gross proceeds ~$150M.","Underwriters granted 30-day option to purchase up to 1,875,000 additional shares on same terms.","Underwriting syndicate led by J.P. Morgan, Jefferies, Piper Sandler, and Guggenheim Securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-163546","json":"https://secwatch.observer/filing/0001193125-23-163546.json","markdown":"https://secwatch.observer/filing/0001193125-23-163546.md","text":"https://secwatch.observer/filing/0001193125-23-163546.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622229/000119312523163546/0001193125-23-163546-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622229/000119312523163546/d518843d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:59:38.403324+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d4150c6d567f714c44d124e0860664e2d769c266","claim":"Cogent Biosciences, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, Jefferies LLC, Piper Sandler & Co. and Guggenheim Securities, LLC, as the representatives of the underwriters valued at $150 million (effective 2023-06-06).","evidence_excerpt":"On June 6, 2023, Cogent Biosciences, Inc. (the “Company”) entered into an underwriting agreement (“Underwriting Agreement”) with J.P. Morgan Securities LLC, Jefferies LLC, Piper Sandler & Co. and Guggenheim Securities, LLC, as the representatives of the underwriters named therein (the “Underwriters”), to issue and sell 12,500,000 shares of the Company’s common stock at a public offering price of $12.00 per share (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312523163546/0001193125-23-163546-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"J.P. Morgan Securities LLC, Jefferies LLC, Piper Sandler & Co. and Guggenheim Securities, LLC, as the representatives of the underwriters"},{"label":"Value","value":"$150 million"},{"label":"Effective","value":"2023-06-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}